These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28604997)

  • 1. Early diagnosis of radiotherapy failure for patients with head and neck cancer: the role of biochemical markers.
    Mrochem-Kwarciak J; Rutkowski T; Wygoda A; Deja R; Hajduk A; Składowski K
    Tumori; 2018 Aug; 104(4):273-279. PubMed ID: 28604997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours.
    Banal A; Hacene K; Berthelot-Ruff E; Mahé E; Fontana X; Pichon MF
    Tumour Biol; 2001; 22(1):27-35. PubMed ID: 11054024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of therapy in head and neck patients during the radiotherapy by measurement of Cyfra 21-1.
    Pradier O; Hille A; Schmiberger H; Hess CF
    Cancer Radiother; 2002 Feb; 6(1):15-21. PubMed ID: 11899676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma?
    Rudhart SA; Schultz JD; Gehrt F; Pavel FL; Birk R; Hoch M; Stuck BA; Hoch S
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3467-3475. PubMed ID: 31482332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen.
    Yen TC; Lin WY; Kao CH; Cheng KY; Wang SJ
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):82-6. PubMed ID: 9563673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
    Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
    Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck.
    Ogawa T; Tsurusako Y; Kimura N; Nishioka S; Akagi H; Nishizaki K; Nishioka K; Rutka J
    Acta Otolaryngol Suppl; 1999; 540():72-6. PubMed ID: 10445084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of cyfra 21-1, a tumor marker, in head and neck squamous cell carcinoma.
    Céruse P; Rabilloud M; Charrié A; Dubreuil C; Disant F
    Ann Otol Rhinol Laryngol; 2005 Oct; 114(10):768-76. PubMed ID: 16285267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck.
    Kuropkat C; Lippert BM; Werner JA
    Oncology; 2002; 63(3):280-5. PubMed ID: 12381908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.
    Pras E; Willemse PH; Canrinus AA; de Bruijn HW; Sluiter WJ; ten Hoor KA; Aalders JG; Szabo BG; de Vries EG
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):23-32. PubMed ID: 11777619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
    Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
    Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of CYFRA 21-1 and CEA in patients with undifferentiated nasopharyngeal carcinoma before and after radiotherapy].
    Zhu WQ; Sun XD; Xie P; Kong L; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):367-70. PubMed ID: 21875467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the usefulness of CYFRA 21-1 as a tumor marker in squamous cell carcinomas of the head and neck].
    Sano K; Kataoka S; Katoh T; Kawauchi H; Morikawa S
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Jul; 100(7):790-7. PubMed ID: 9277101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
    Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
    Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
    Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
    Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
    Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P
    Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.
    Cho A; Hur J; Hong YJ; Lee HJ; Kim YJ; Hong SR; Suh YJ; Im DJ; Kim YJ; Lee JS; Shim HS; Choi BW
    Tumour Biol; 2016 Mar; 37(3):3205-13. PubMed ID: 26432331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
    Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
    BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.